ESC 365 - Management of cardiac transthyretin amyloidosis with or without aortic stenosis – discussion.

ESC Professional Premium Access

Management of cardiac transthyretin amyloidosis with or without aortic stenosis – discussion.

Session: Management of cardiac transthyretin amyloidosis with or without aortic stenosis

Topic: Treatment

Event: ESC Congress 2022

Congress Presentation

3 more presentations in this session

What is ATTR cardiac amyloidosis and how is it diagnosed?

Speaker: Doctor M. Corneli (Buenos Aires, AR)

How should ATTR cardiac amyloidosis cardiomyopathy be treated?

Speaker: Professor T. Damy (Creteil, FR)

How common is ATTR cardiac amyloidosis in aortic stenosis and how does it impact on management?

Speaker: Doctor T. Treibel (London, GB)

Access the full session

Management of cardiac transthyretin amyloidosis with or without aortic stenosis

Speakers: Doctor M. Corneli, Professor T. Damy, Doctor T. Treibel

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources